Labiotech.eu

News and Trends 10 Oct 2025

Practical partnering at BIOSPAIN: on the ground with biotech innovators ready to take the next step

We were on the ground in Barcelona speaking to biotech companies, university technology transfer offices, and top pharma firms about their experience at BIOSPAIN and their progress towards securing partnerships.

October 10, 2025 - 8 minutesmins - By Dylan Kissane

Podcast 10 Oct 2025

Contraline’s ADAM in the clinic: towards a new era of male contraception?

In this week’s podcast we talked with Kevin Eisenfrats, CEO of Contraline, about contraception, male contraception.

October 10, 2025

News and Trends 9 Oct 2025

Are European biotech VCs under pressure to scale? Time to get pragmatic

As Asabys Partners has rolled Aliath Bioventures into its platform, it’s worth asking if European biotech VCs are under pressure to scale.

October 9, 2025 - 5 minutesmins - By Jules Adam

News and Trends 8 Oct 2025

Top biotech deals in September 2025

Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals were signed.

October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 7 Oct 2025

Six companies leading the mRNA revolution in biotechnology

Here are six mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials.

October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter

Is AKIGAI's EGFR inhibitor the next big thing in neuropathic pain

In Depth 7 Oct 2025

AKIGAI takes EGFR inhibitors beyond cancer to treat neuropathic pain

Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome (CRPS).

October 7, 2025 - 9 minutesmins - By Jules Adam

In Depth 3 Oct 2025

The biggest biotech funding rounds in September 2025

uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025.

October 3, 2025 - 5 minutesmins - By Willow Shah-Neville

Podcast 3 Oct 2025

Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play

This week, we discussed funding with Gerard Caelles, Chief Business Office of Splice Bio, a company that just closed a $135 million series B round.

October 3, 2025

News and Trends 1 Oct 2025

Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector?

Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines.

October 1, 2025 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 1 Oct 2025

Asthma study suggests lung scarring may be reversible

Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible.

October 1, 2025 - 7 minutesmins - By Jules Adam

Best in Biotech 30 Sep 2025

CRISPR technology’s next wave: Ten companies to watch in 2025

Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies.

September 30, 2025 - 15 minutesmins - By Jules Adam

News and Trends 29 Sep 2025

First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics?

FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies?

September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Practical partnering at BIOSPAIN: on the ground with biotech innovators ready to take the next step

Contraline’s ADAM in the clinic: towards a new era of male contraception?

Are European biotech VCs under pressure to scale? Time to get pragmatic

Top biotech deals in September 2025

Six companies leading the mRNA revolution in biotechnology

AKIGAI takes EGFR inhibitors beyond cancer to treat neuropathic pain

The biggest biotech funding rounds in September 2025

Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play

Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector?

Asthma study suggests lung scarring may be reversible

CRISPR technology’s next wave: Ten companies to watch in 2025

First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics?

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!